MAREL Marel hf.

Marel - Transactions in relation to a share buy-back programme

Marel - Transactions in relation to a share buy-back programme

Notification of purchase of own shares under buy-back programme

In week 4, Marel hf. purchased 1,418,520 of its own shares, at the purchase price of ISK 561,396,142. See further details below:

DateTimeNo. of shares boughtShare price (rate)Purchase price (ISK) 
21.1.201911:28:51  283,704 397.00  112,630,488  
22.1.201909:31:39  100,000 395.00  39,500,000  
22.1.201909:34:01  100,000 395.00  39,500,000  
22.1.201909:38:53  25,000 395.00  9,875,000  
22.1.201909:39:54  20,000 395.00  7,900,000  
22.1.201909:42:55  38,704 395.00  15,288,080  
23.1.201909:46:51  100,000 395.50  39,550,000  
23.1.201909:48:26  150,000 395.50  59,325,000  
23.1.201910:30:21  33,704 396.00  13,346,784  
24.1.201909:31:44  283,704 396.25  112,417,710  
25.1.201909:32:43  283,704 395.00  112,063,080  
Total 1,418,520 561,396,142 
     

The trade is in accordance with Marel's buy-back programme, announced by Nasdaq Iceland on 3 December 2018, and based on the authorisation of a shareholders’ meeting of Marel hf. on 22 November 2018.

Marel hf. held 14,196,699 own shares prior to the announced transactions and holds 15,615,219 own shares after them, or the equivalent of 2.29% of issued shares in the company.

Marel hf. has purchased a total of 8,924,669 own shares under the buy-back programme, which corresponds to 1.31% of issued shares in the company, for a total purchase price of ISK 3,421,967,075.

Buy-backs under the programme will amount to a maximum of 17,305,940 million shares, or the equivalent of 2.5% of issued shares. The buy-back programme is in effect from 4 December 2018 until and including 5 March 2019.

The buy-back program was executed in accordance with Chapter VIII. of Act No. 2/1995 on Public Limited Companies and Chapter II of the Annex to Regulation No. 630/2005 on Inside Information and Market Abuse, “Trade in own shares under buy-back programmes and the stabilisation of financial instruments”, with later amendments.

Further information:

Tinna Molphy, Manager in Investor Relations, and Marino Þór Jakobsson, Investor Relations Analyst via or tel: (+354) 563 8001.



EN
25/01/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marel hf.

Martijn Den Drijver
  • Martijn Den Drijver

MAREL HF : A solid quarter, 2024 guidance to be met, slight delay in J...

>Beats on order intake and EBIT (margin), sales a miss, ND/EBITDA down - MAREL beat css on order intake which is encouraging, also because order intake is up both QoQ and YoY (+3%). Sales of €387m missed css by 4%, primarily because of 1/ weak ad-hoc orders as order intake has been weak for a few quarters now and 2/weak sales in Poultry and Fish. Adjusted EBIT came in at €36.2m or a margin of 9.4% versus css of €33.4m or a margin of 8.3%. That is a beat of 8% on adj....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch